Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA: 688192)
China
· Delayed Price · Currency is CNY 48.60
-0.24 (-0.49%)
Dec 3, 2024, 4:00 PM CST
Dizal (Jiangsu) Pharmaceutical Revenue
Dizal (Jiangsu) Pharmaceutical had revenue of 134.90M CNY in the quarter ending September 30, 2024, with 236.39% growth. This brings the company's revenue in the last twelve months to 389.64M, up 871.61% year-over-year. In the year 2023, Dizal (Jiangsu) Pharmaceutical had annual revenue of 91.29M.
Revenue (ttm)
389.64M
Revenue Growth
+871.61%
P/S Ratio
51.29
Revenue / Employee
670.63K
Employees
581
Market Cap
20.20B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition